Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
Corbin Davis
Authored Items
Monoclonal Antibodies: The Future of Migraine Therapy
Corbin Davis
Migraine
VBCN - July 2016 Volume 3, No 2
New Indications for Novel Antiepileptic Drugs May Offer Advantages for Patients with Seizures
Corbin Davis
Epilepsy
VBCN - July 2016 Volume 3, No 2
Alemtuzumab Most Cost-Effective Multiple Sclerosis Treatment for Achieving No Evidence of Disease Activity
Corbin Davis
Health Economics
VBCN - July 2016 Volume 3, No 2
Stroke Center Reduces Door-to-Needle Times to Less Than 30 Minutes
Corbin Davis
Stroke
VBCN - May 2015 Volume 2, No 1
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to recieve the free
VBCN
e‑Newsletter.
I'd like to recieve:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.
